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Human T lymphocytes express human leukocyte antigen (HLA)-DR-alpha (DRA) upon mitogenic or
antigenic stimulation. DR' T cells are also found in a number of inflammatory and autoimmune diseases and
have a proposed role in these diseases. The molecular mechanism of DR regulation in untransformed blood T
lymphocytes was studied here by transient transfection of DRA-chloramphenicol acetyltransferase reporter
gene constructs. Several novel features of this regulation were observed. During the early stages of T-cell
activation by mitogens or antigens, strong promoter induction was exhibited with the proximal 43 bp of the
DRA promoter which contains a TATTA motif. Addition of upstream X and Y DNA elements augmented the
response. This contrasts with data from transformed cell lines in which the proximal 43 bp produced no
detectable promoter function, and the inclusion of X and Y elements is essential for basal level expression.
Mutation of the TATTA motif or substitution with a functional but different TATA element produced errant
initiation and greatly reduced gene expression. Interestingly, T lymphocytes from a normal donor were DR'
prior to in vitro stimulation, and again, strong promoter activity was observed with 43 bp of proximal
sequence. Unexpectedly, the presence of the X and Y elements correlated with a suppression of class H
promoter function and surface antigen expression. This study of nontransformed lymphocytes reveals several
novel features of DRA gene regulation and underscores the value and necessity of such studies.
Class II human leukocyte antigens (HLA) are central for
immune responsiveness to foreign antigens. A variety of
immune cells displays different patterns of class II expres-
sion. For example, B cells and dendritic cells and some
macrophages express class II antigens constitutively,
whereas other macrophages, microglia, astrocytes, vascular
endothelium, and human T cells do not normally express
class II unless stimulated by antigen, cytokine, or mitogen
(3, 7, 14). The underlying molecular mechanisms which
regulate the complex patterns of expression in these various
immune cells are only partially understood.
A number of cis-acting and trans-acting promoter ele-
ments important for the transcriptional regulation of class II
genes have been identified by using transformed cell lines as
reviewed previously (1, 3, 7, 14, 27, 37). Most class II
promoters contain three conserved proximal upstream se-
quences: the W/Z element, X element, and Y element. The
HLA-DR-alpha (DRA) gene also contains an additional
octamer element originally found in the promoter and en-
hancer of immunoglobulin genes. The minimal length of the
DRA promoter required for proper gene activation includes
the region containing a TATA-like element as well as the X
and Y elements collectively known as the class II box. The
TATA element acts as a target sequence for the transcription
factor, TFIID (TBP), which initiates the assembly of the
transcription complex (15). Further upstream from the
TATA, the Y element contains a reversed CCAAT box, and
it forms DNA-protein complexes with specific transcription
factor YB-1 (8) or NF-Y/YEBP (16, 45). The X element is
divided into the 5' X1 and 3' X2 sequences which interact
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with RF-X (29, 30) and hXBP-1 (20), respectively. These two
sequences are essential for the activation of class II major
histocompatibility (MHC) genes. Further upstream from the
class II box are two additional elements: the W region
contains a conserved sequence known as the Servenius
element (32), which can enhance gene expression by four- to
fivefold, and a V region which acts as a cis-acting negative
regulatory element (6). The importance and interdependence
of these cis elements, particularly the conserved X and Y
elements, are illustrated by the requirement of stereospecific
and spatial alignment of these elements (42). Disruption of
the distance between elements and/or their helical alignment
on the DNA greatly diminishes class II gene activation.
HLA class II antigens are present on human T cells
activated by mitogens such as pokeweed mitogen, concana-
valin A or phytohemagglutinin (PHA) (17, 44), alloantigens
(5, 13, 23), peptide antigens (12, 19), and anti-CD3 antibody
which recognize the T3 subunit of the T-cell receptor com-
plex (24, 31). In addition, HLA class II expression is a
hallmark of T cells isolated from patients with a number of
bacterial and viral infections (28, 44) and autoimmune dis-
eases such as systemic lupus erythematosus and rheumatoid
arthritis (36, 44). In certain autoimmune diseases, the T cells
appear to be chronically activated; however, the activating
agent has not been identified. Other proliferative stimuli of T
cells such as phorbol myristate acetate do not induce class II
expression on T cells (24). Thus, a specific signal(s) that is
distinct from the proliferative signal appears to induce the
expression of HLA class II molecules on T cells.
Previous studies suggest that the TATA box, central to the
formation of the preinitiation transcription complex, does
not influence basic transcription of class II MHC genes (3,
43). Instead, the class II box containing X and Y elements is
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sufficient for proper transcriptional activity. In this report,
the molecular regulation of the HLA-DRA promoter in
untransformed human blood T cells activated by different
stimuli was found to differ significantly from transformed cell
lines. We provide evidence that the TATA region is critical
for DRA promoter activity during T-cell activation and
augments the positive regulation provided by the X and Y
elements of the class II box. In addition, the role of the class
II box and the TATA-containing region changed during
different times following T-cell stimulation. Finally, a novel
role of the class II box as a negative regulatory element was
observed in DR' T lymphocytes from a donor. Relief of this
suppression upon mitogen stimulation was tightly associated
with higher surface DR expression. These novel features of
DRA gene regulation underscore the importance of studying
gene regulation in primary untransformed cells.
MATERIALS AND METHODS
DRA promoter mutants. Plasmid constructs containing
-109, -53, or -43 bp of the 5' flanking sequences of the
HLA-DRA gene linked to the bacterial chloramphenicol
acetyltransferase (CAT) gene and the negative control
(pD164-2) have been previously described (see Fig. 2A) (33,
34). Additional site-specific mutations of the DRA promoter
region were made according to the procedure of Kunkel et
al. (18). All mutations were made by using 5'A-152 WT
DRA-CAT as the template. It contains 152 bp of DRA
promoter sequence linked to the CAT gene cloned in a
pBluescript SK+ phagemid (Stratagene, La Jolla, Calif.) as
previously described (22). Mutations made within the Y and
X elements are as follows with the mutations underlined: Y
element mutant, Y-M1, 5'-G1GAGJTICC-3'; X1 element
mutant, X-M1, 5'-AATAGIAAI-3'; and X2 element mu-
tant, X-M2, 5'-ACATACA-3' as previously described (22).
Mutations within the TATA region were made by using
oligonucleotides containing mutations 5' and 3' of the TATA
box and within the TATA box. The resultant mutants called
TM-1 through TM-5 are shown in Fig. 4A. All mutants were
transformed into DH5a Eschenichia coli, and mutant plas-
mids isolated from clones were all characterized by direct
DNA sequence determination. The corresponding negative
control plasmid, CAT-SK+, lacks the DRA promoter se-
quence.
Flow cytometric analysis. Samples of T cells were labelled
with primary monoclonal antibodies at predetermined dilu-
tions. Gammapak (Genex, Gaithersburg, Md.)-purified anti-
CD3 (immunoglobulin G2a [IgG2a]) and anti-CD3 superna-
tants from ATCC CRL 8001 hybridoma were a kind gift of
Olivera Finn, University of Pittsburgh. Antibodies for the B1
(IgG2a) and MY-4 (IgG2b) markers for B cells and macro-
phages, respectively, were purchased from Coulter Immu-
nology (Hialeah, Fla.). Monoclonal anti-HLA-DR mono-
morphic (IgG2a) antibodies were produced by ATCC HB 55
(Rockville, Md.). Cells were labelled for 30 min at 4°C,
washed two times in phosphate-buffered saline (PBS), and
subsequently labelled with a secondary antibody consisting
of either fluorescein isothiocyanate conjugated to goat anti-
mouse IgG (Organon Teknika, West Chester, Pa.) or phyco-
erythrin conjugated to goat anti-mouse IgG2a for 30 min at
4°C. Cells were washed two times and fixed in 0.5% para-
formaldehyde. Analysis of the populations was performed
with a Coulter Epic 751 (Coulter Electronics, Inc., Hialeah,
Fla.).
Preparation of T cells. Peripheral blood leukocytes (PBLs)
from normal donors were isolated by a modified protocol
described by Boyum (4). Briefly, whole blood diluted in PBS
was centrifuged through histopaque 1077 (Sigma Chemical
Co., St. Louis, Mo.) at 2,000 rpm (450 x g) in an IEC CRU
5000 (Needham Heights, Mass.) for 30 min. The interface
was removed and washed with PBS and centrifuged once at
1,500 rpm (200 x g), three times at 1,200 rpm, and once at
800 rpm to remove the platelets. Subsequently, the cells
were placed onto a Percoll gradient of 65, 55, and 46% and
centrifuged to remove the monocytes (40). The cells were
washed three times in PBS, resuspended in complete T-cell
medium (21), and plated onto 100-mm tissue culture plates
(Falcon, Lincoln Park, N.J.). These cultures contained
residual monocytes which serve as antigen-presenting cells
for antigen-stimulated and mixed lymphocyte culture
(MLC)-stimulated T-cell experiments. Cultures were main-
tained in a 7% CO2 incubator at 37°C for 3 days to eliminate
the B-cell population. For anti-CD3 stimulation, T cells were
replated onto 100-mm tissue culture plates in fresh complete
T-cell medium for 2 h at 37°C to remove any residual
monocytes. Nonadherent T cells were washed off the plates,
centrifuged, and resuspended in T-cell media. Flow cytomet-
ric analysis of these isolated T cells with anti-CD3 as a
marker showed a greater than 98.5% enrichment of CD3+ T
cells.
Stimulation of T cells. Two-way MLC was conducted by
mixing 5 x 106 PBLs (described above) per ml from two
different donors in 75-cm2 tissue culture flasks (Falcon)
containing complete T-cell media. The cultures were incu-
bated at 37°C in 7% CO2 and cultured for the indicated
number of days prior to transfection with plasmid DNA.
PHA was obtained from Sigma and was used at 2 Ag/ml to
stimulate PBLs cultured at 5 x 106/ml in 100-mm tissue
culture plates. Cells were cultured for 3 days or as indicated
in Results.
Purified protein derivative (PPD) antigen made from AMy-
cobacterium tuberculosis was used at 50 ,ug/ml to stimulate
PBLs. Cells were cultured at 5 x 106/ml in 100-mm tissue
culture plates (Corning, Corning, N.Y.) and incubated at
37°C for 5 days prior to transient transfection with plasmid
DNA.
For anti-CD3-stimulated T cells, goat anti-mouse IgG(Fc)
diluted in PBS in a fixed concentration of 5 ,ug/ml was added
to 100-mm plastic tissue culture plates for 4 h and subse-
quently washed three times prior to the addition of 1.5 ,ug of
anti-CD3 monoclonal antibody per ml in 0.5% bovine serum
albumin. The plates were incubated for an additional 2 h and
washed gently four times with PBS. Highly enriched T cells
were added at 5 x 106/ml and cultured at the times indicated.
Transient transfection of primary lymphocytes. For MLC-,
PPD-, and PHA-stimulated cultures, all cell preparations
were subjected to two sequential plastic adherence to re-
move monocytes and sheep erythrocyte rosetting (26) to
purify the T cells prior to electroporation. This procedure
resulted in an 85 to 95% enrichment for T cells as analyzed
by flow cytometry. The anti-CD3 cultures remained highly
enriched (>99%) for T cells as described earlier and did not
require further purification prior to electroporation. Each
DNA plasmid was added at 25 ,ug/10 ,ul in a 300-,ul final
volume of media containing 3 x 106 to 5 x 106 cells. This
mixture was incubated for 10 min on ice and transferred to
the Gene Pulser cuvette (Bio-Rad, Richmond, Calif.), which
was subsequently placed in the chamber of the Bio-Rad
Gene Pulser. Electroporation parameters were 260 V and
960 ,uF by using the Bio-Rad capacitance extender. Cells
were transferred to 12-well Costar tissue culture plates
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(Cambridge, Mass.) after electroporation and incubated at
37°C for 24 h.
CAT assay. Assessment of CAT activity was performed as
previously described (22, 33). Briefly, cells were harvested
from tissue culture wells into 1.5-ml Eppendorf tubes, and 1
x 10 to 2 x 106 cells were washed twice in PBS and
resuspended in 25 p,l of 250 mM Tris buffer (pH 7.6) and
lysed by freeze-thawing in an ethanol-dry ice bath. Samples
were centrifuged, and the organic extracts were assayed for
CAT enzyme by using [14C]chloramphenicol (New England
Nuclear, Boston, Mass.), acetyl coenzyme A buffered in 250
mM Tris (pH 7.6). The reaction was allowed to incubate at
37°C from 6 to 24 h and terminated by the addition of ethyl
acetate. The extracts were blotted onto chromagram thin-
layer chromatography (Eastman Kodak, Rochester, N.Y.)
and the acetylated forms of chloramphenicol were visualized
by autoradiography. The thin-layer chromatography plates
were quantitated for 14C radioactivity by a 1214 Rackbeta
counter (LKB Instruments, Gaithersburg, Md.) or by the
AMBIS radioanalytic imaging system (AMBIS Systems, San
Diego, Calif.). Percent acetylation was calculated as 100 x
(counts per minute of the acetylated forms/total counts per
minute). Fold induction was calculated by dividing the
percent acetylation from the DRA promoter-containing CAT
plasmids by the percentage from the plasmid without DRA
promoter. Statistical analysis of two values was conducted
by using the Student's t test.
In vitro transcription nuclear extract. Raji B-lymphoblas-
toid cells were used to prepare nuclear extract by using a
modification of the Dignam procedure (11) as described
previously (45).
In vitro transcription assays. Transcription reactions were
performed as previously described (38, 45). Plasmids 5'A-152
DRA-CAT and T-M1 were linearized with NcoI and were
used as templates for transcription to produce a 595-bp
transcript. Radiolabelled internal standard consisted of a
494-base transcript (kindly supplied by R. Kole, University
of North Carolina) which was added to each reaction (2,000
cpm per reaction) to serve as a control for RNA recovery.
RESULTS
Cell surface HILA-DRA expression on activated primary T
cells. MLC, anti-CD3, and PHA stimulation have been
previously shown to induce class II expression on human T
lymphocytes. Figure 1A confirms these findings; the kinetics
of class II expression on T cells stimulated by MLC shows a
gradual increase over 3 days, reaching a peak at approxi-
mately day 3. A disadvantage of MLC is that matching
donors is difficult and it contains a heterogeneous population
of antigen-presenting cells as well as T cell, B cell, and other
cell types responding to alloantigen. We alleviated most of
these variables by stimulating T cells with immobilized
anti-CD3 antibody. As in MLC-stimulated T cells, T cells
activated by immobilized anti-CD3 antibody also induced a
similar kinetics of cell surface class II antigen expression
FIG. 1. Percentage of activated human T cells expressing cell
surface HLA-DR molecules. T cells from various normal donors
were activated in either MLC (A), immobilized anti-CD3 antibody
(B), or PHA (C) over a 5-day incubation period. The T cells were
harvested at the indicated days and dual labelled to detect DR'
CD3+ T cells by flow cytometry. A minimum of three donors was
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FIG. 2. Transfection of primary human T cells activated by MLC, anti-CD3, or PHA. (A) 5'A-43 contains the DRA promoter sequences
including the TATA box, 5'A-53 further contains the octamer, and 5'A-109 contains the X and Y elements. pD164-2 is a negative control
containing the CAT gene but not DRA sequences. (B) CAT activity produced by primary human T cells transiently transfected and activated
for the days indicated. Extracts of T cells transfected with pD164-2, 5'A-43, or 5'A-109 were analyzed for CAT activity by thin-layer
chromatography and quantitated by AMBIS. The histograms show relative amounts of acetylated chloramphenicol reaction products. Panels
A, B, and C are anti-CD3-stimulated T cells from three different donors. Panels D, E, and F are PHA-stimulated T cells from three different
donors. Panel G is a two-way MLC. Fold induction is calculated as described in the text with the negative control (pD164-2) assigned a value
of 1.
over a 5-day period, although the values are slightly lower
than those for allogeneic T cells (Fig. 1B). PHA-stimulated T
cells displayed a similar pattern (Fig. 1C). Unstimulated
resting T cells do not express significant (<4%) HILA class II
antigens (data not shown). The mean number of DR' T cells
is greater in PHA stimulation than in anti-CD3 stimulation;
however, analysis of the standard deviation suggests no
significant difference between these two populations. Over-
all, a high degree of donor variability was observed, concur-
ring with previous findings by others (17, 23).
Kinetic analysis of DRA promoter function in activated T
cells. Preliminary transfections with plasmids shown in Fig.
2A displayed different requirements for the promoter ele-
ments in alloantigen-, PPD-, or anti-CD3-stimulated T cells
assayed on day 6 compared with PHA-stimulated T cells
assayed on day 3 (data not shown). It is critical to determine
if this difference in reporter gene activity is due to different
stimulatory signals, to different times of assay, or to a
difference in the kinetics of T cells activated by mitogen
versus antigen. To distinguish between these possibilities, T
cells were stimulated by MLC, immobilized anti-CD3 anti-
body, or PHA for various intervals and transiently trans-
fected with 5'A-43, 5'A-53, 5'A-109, or the negative control
pD164-2.
T cells stimulated by immobilized anti-CD3 antibody were
examined first. A kinetic analysis ofDRA promoter usage in
anti-CD3-stimulated T cells from five donors was performed,
and significant donor-to-donor variations were observed as
exemplified in the three experiments shown (Fig. 2B, panels
A, B, and C). This is expected on the basis of other studies
Fold Induction t7
Days of Culture 1
VOL. 12, 1992
5614 MATSUSHIMA ET AL.
(10, 23, 24) and our analyses of DR surface expression on T
lymphocytes (Fig. 1). Nonetheless, several general conclu-
sions can be drawn from these data. Foremost, there is
significant CAT expression from the 5'A-43 construct over
the negative control while inclusion of X and Y elements in
the 5'A-109 construct further augmented CAT expression.
The level of significance for these differences wasP < 0.025.
In two of three donors (panels B and C), CAT activity
gradually increased upon addition of the stimulant, reaching
a peak by day 3 and then subsiding by day 4. In one donor
shown in panel A, CAT activity was high on day 1, sustained
until day 3, and then gradually decreased. On day 6, CAT
expression was reactivated from the 5'A-109 construct with-
out an increase of CAT activity (P < 0.001) from the 5'A-43
construct (Fig. 2B, panel A) or from the 5'A-53 construct
(data not shown). This pattern of reactivated CAT expres-
sion on day 6 was observed in T cells from several donors,
including T cells stimulated by alloantigens and PPD (data
not shown). In an MLC (Fig. 2B, panel G), the 5'A-43
construct expressed significant CAT activity over the nega-
tive control when the cells were activated and assayed by 1
to 4 days, and the presence of the class II box further
enhanced CAT expression. Day 5 produced the lowest CAT
activity for all constructs tested. However, by day 6 the cells
exhibited high class II box (5'A-109) promoter activity with-
out significant expression from the 5'A-43 construct (Fig. 2B,
panel G) or the 5'A-53 construct (data not shown). This
pattern of promoter activity exhibited by 5'A-43 was signif-
icantly different from the 5'A-109 construct (P < 0.05) and
was confirmed by using T cells from two other donors which
were stimulated by MLC for 6 days. These data suggest that
T cells stimulated by anti-CD3 antibody (Fig. 2B, panel A) or
in MLC (Fig. 2B, panel G) respond with two waves of
promoter element usages and point out the dynamic nature
of gene regulation in primary T lymphocytes.
PHA-stimulated T cells from three donors (Fig. 2B, panels
D to F) showed significant levels (P < 0.025 compared with
the negative control) ofCAT expression produced by 5'A-43.
5'A-53 also gave results identical to those of the 5'A-43
construct (data not shown). At all early times, inclusion of
the class II box substantially augmented CAT expression, as
observed for the anti-CD3-stimulated T cells. During the
later times, a decrease in transcription occurred for both
5'A-43 (P < 0.025) and 5'A-109 (P < 0.001) without a
reactivation of CAT produced by 5'A-109 on day 6. The
diminished transcription was uniform for both 5'A-43 and
5'A-109. These patterns of DR promoter usage in primary T
cells were observed in two other donors in addition to the
ones shown.
The X and Y elements of the class II box are required for
promoter induction in T cells. Previous studies of various
class II-expressing murine cells in transgenic animals indi-
cate different requirements for X or Y elements (41). These
studies have not been performed with any human primary
cells. To assess this in human primary T lymphocytes, the
expression of a number of DRA promoter constructs with
site-specific mutations (22) was studied. Figure 3 shows that
both the Y and X elements are critical for class II expression
in T cells. Mutagenesis of the Y or X element in Y-M1 (lane
3), X-M1 (lane 4), and X-M2 (lane 5) dramatically reduced (P
< 0.025) CAT signal compared with the positive control
5'A-152 WT (lane 2). The negative control CAT-SK+ (lane 1)
did not produce a signal, as expected. This observation was
consistent in five experiments using a different donor for
each experiment.
The TATA box is critical for reporter gene expression in
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FIG. 3. Transient transfection of primary human T cells with
CAT reporter plasmids containing mutations within the X and Y
elements of the DRA promoter. Freshly isolated T cells were
stimulated by immobilized anti-CD3 antibody and transfected on
day 3. Cells were harvested 24 h later, and acetylated CAT products
in cell extracts were separated by thin-layer chromatography and
quantitated by AMBIS (% AC). CAT-SK+ is the CAT-containing
negative control plasmid, 5'A-152 WT contains 152 bp of the DRA
promoter, Y-M1 contains a mutated Y element, X-M1 contains a
mutated X1 element, and X-M2 contains a mutated X2 region.
Similar results were obtained from five other experiments.
primary T lymphocytes as well as transformed cell lines. To
determine the DNA sequence within 5'A-43 that may be
eliciting promoter activity, site-specific mutagenesis was
employed. The most obvious motif that may be important for
promoter function is TATTA at position -24 bp, although its
involvement in class II MHC promoters is controversial (see
Discussion). To examine the role of the TATTA motif and
juxtaposed sequences, four mutants were made as shown in
Fig. 4A. In two of these mutants, T-M3 and T-M4, respec-
tively, sequences immediate upstream and downstream of
the TATTA box were mutated. In T-M1, the DRA TATTA
box was replaced with TjQTCA. Finally, in T-M5, the DRA
TATTA sequence was substituted with the simian virus 40
(SV40) TATA box. The rationale for this is if the TATTA
sequence in DRA promoter is serving the proposed function
in transcription initiation, a complete random change of this
sequence would obliterate gene expression. Substitution of
one TATA motif for another functional TATA would permit
us to decipher if DRA promoter activation is occurring
through a specific TATA element present in the DRA
promoter.
Transfection of TM1 to TM5 mutants into PHA-stimulated
T lymphocytes indicates that the TATTA motif in the DRA
promoter is indeed pivotal. A representative of nine exper-
iments shown in Fig. 4B indicates that mutations of the 5'
and 3' sequences flanking the TATA box (lanes 3 and 4,
respectively) produced no reduction of CAT activity com-
pared with the wild-type 5'A-152 (lane 2). In fact, in approx-
imately half of the experiments, these mutations actually
enhanced CAT expression (data not shown). In stark con-
trast, substitution of the DRA TATTA with the SV40 TATA
box dramatically reduced CAT expression (lane 5). Simi-
larly, in a separate experiment (Fig. 4C), a radical mutation
of the TATA box (T-M1) (lane 4) also greatly reduced CAT
activity. These results show that the DRA TATA box is
indeed important for class II promoter function in primary T
lymphocytes.
Because of the controversial nature of the TATA box in
class II MHC promoters, we further examined the general
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TATA AND CLASS II BOX OF DRA IN PRIMARY T CELLS 5615
A x
W X Y O TATTA












% AC 2.6 59.3 6.9
LANES 1 2 3
C
% AC 0.2 91.7 0.2
LANES 1 2 3








% AC 2.5 88.9 93.0 11.3
._ r * LANES 1 2 3 4
% AC 3.1 94.7 96.2 91.6 6.8
LANES 1 2 3 4 5
FIG. 4. Transient transfection of primary human T cells with
CAT reporter plasmids containing mutations within the TATA
region of the DRA promoter. (A) Sequence of site-specific mutations
within the TATA region. The TATA box is shaded. Mutated
sequences are underlined. The names of these mutants are T-M1,
T-M3, T-M4, and T-M5. (B) T cells activated by PHA were
transfected on day 2 and assayed for CAT activity (% AC) 24 h later.
CAT-SK+ is the negative control, 5'A-152 WT is the parent plasmid
containing 152 bp of the DRA promoter, T-M3 contains mutation in
the 5' flanking region of TATTA, T-M4 contains mutations in the 3'
flanking region of TATTA, and T-M5 contains the SV40-substituted
TATTTAT box. (C) PHA-stimulated T cells transfected with the
plasmid containing the mutated TATTA box. CAT-SK' is the
negative control, T-M3 is the mutated 5' flanking region of TATTA,
T-M4 is the mutated 3' flanking region of TATTA, and T-M1 is the
mutated TATA box. The level of significance for the reduction of
CAT activity by T-M5 and T-M1 are P < 0.005 and P < 0.05,
respectively.
involvement of this motif in other cells. A T-cell line which
constitutively expresses DR, H9, and the B-lymphoblastoid
line Raji were tested in transient transfection assays. Again,
mutation of the TATA box (T-M1) obliterated gene expres-
sion as shown in Fig. SA and B (compare lanes 2 and 3 in
each experiment). To determine if this was due to aberrant
initiation of transcription, in vitro transcription analysis was
performed by using nuclear extract from the Raji B-lympho-
blastoid cell line. As seen in Fig. SC, three concentrations of
494 bp- ..o-
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FIG. 5. Requirement of the TATA box for DRA promoter func-
tion. (A) An example from two transient transfection experiments of
the T-cell line H9. CAT-SK+ is the negative control; 5'A-152 WT is
the wild-type construct, and T-M1 contains the mutated TATA box.
The difference between CAT activity (% AC) generated by 5'A-152
and T-M1 has a P < 0.05 value. (B) Transient transfection of Raji B
cells. Lanes 1 to 3 are identical to Fig. 5A. These experiments were
repeated three times. The difference between 5'A-152 and T-M1 has
a P < 0.025 value. (C) In vitro transcription with nuclear extracts
from Raji. Lanes 1, 2, and 3 show transcripts (595 bp) from the
5'A-152 WT template at three different concentrations of DNA.
Lanes 4, 5, and 6 show aberrant transcripts from the T-M1 template.
A radiolabelled 494-bp transcript serves to control for RNA recov-
ery in each reaction. An example of four in vitro transcription assays
is represented.
the wild-type control (lanes 1 to 3) produced a transcript of
the predicted size. In contrast, mutation of the TATA region
resulted in the production of two aberrantly initiated tran-
scripts. Thus, in our hands, the TATA box of the DRA
promoter appears to play a conventional role in fixing the
site of transcriptional initiation.
In vivo significance of DRA promoter usage: novel roles of
promoter elements in a DR' donor. Resting T cells do not
normally express class II antigens on their cell surface;
however, unstimulated T lymphocytes from a normal donor
monitored over a period of 6 months were found to consis-
tently display elevated levels of surface DR molecules. This
donor was 1 of 20 different individuals whose "normal"
PBLs were analyzed in this study. In other individuals, less
than 5% of the T cells expressed DRA molecules, and these
cells exhibited no detectable DRA promoter activity as
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FIG. 6. DR' T cells from a donor display novel DRA promoter usage. (A) Transient transfection of PHA-stimulated T cells with DRA
promoter deletion constructs shown in Fig. 2A. Lanes 1, 4, 7, 10, 13, 16, and 19, negative control, pD164-2; lanes 2, 5, 8, 11, 14, 17, and 20,
5'A-43; lanes 3, 6, 9, 12, 15, 18, and 21, 5'A-109. (B) Flow cytometric analysis of CD3+ DR+ T cells from PHA-stimulated culture shown in
panel A. Percentages of double-positive T cells are indicated above each panel.
To examine the regulation ofDRA in the T lymphocytes of
this donor, a kinetic analysis with different DRA-CAT con-
structs (Fig. 6A) was performed in parallel with a cytofluo-
rometric analysis (Fig. 6B) for surface DR expression. At
day 0, 14.3% of the CD3-positive cells from this donor were
expressing surface DR antigens (Fig. 6B, panel 1). Parallel
CAT analysis at this time shows low CAT expression
produced by 5'A-109 but a surprisingly high level of CAT
produced by 5'A-43 construct (Fig. 6A, lanes 1 to 3). This
suggests that the class II box present in 5'A-109 is actually
serving a suppressive role, resulting in >70% suppression.
Days 1 and 2 after addition of PHA, the percentage of
DRA-positive cells increased to 19.7 and 21.5%, respectively
(Fig. 6B, panels 2 and 3). Most interesting, the suppressive
effect of the class II box was also relieved at these two times
as indicated by parallel CAT assay (Fig. 6A, lanes 4 to 9).
The presence of the class II box resulted in a slight suppres-
sion on day 1 (compare lanes 5 and 6) which was not
observed on day 2 at the height of surface DR expression
(compare lanes 8 and 9). From days 3 through 5, the
percentage of DR' cells dropped to 14.4% and finally to
9.4% (Fig. 6B, panels 4 to 6). Parallel CAT analysis also
shows that the suppressive effect of the class II box was
regained during this time frame (Fig. 6A, lanes 10 to 18).
These results reveal a novel role for the class II box and
suggest that relief of this suppression can result in elevated
surface DR expression. Thus, the TATA-containing region is
highly active in this individual and may be down-regulated
by the upstream X and/or Y element.
DISCUSSION
Previous studies of DRA gene expression have been
conducted primarily with immortalized cell lines (3, 7, 14).
These studies have demonstrated that the cis-acting X and Y
elements are positive DNA sequences critical for class II
expression. However, T-cell mitogens or antigens known to
activate DR expression on primary T lymphocytes exert no
effect on DR expression by DR' or DR- T-cell lines. This
limitation of human T-cell lines accentuates the importance
of studies with primary T cells.
Our study of DRA expression in activated primary human
T cells has demonstrated a novel usage of a 43-bp region of
the DRA promoter that contains a TATTA sequence. This
43-bp segment does not contain the X and Y elements but
does contain the TATA box as the only recognizable ele-
ment. This activity was typically more obvious during the
early times of T-cell stimulation. Mutation of the TATA box
and substitution with an alternate TATA sequence abrogated
much of the activity, suggesting that this specific sequence is
critical. Inclusion of the X and Y boxes in the DRA promoter
further augmented transcriptional activity. Site specific-
mutagenesis shows that both the X and Y elements are
important for this augmented expression in a great majority
of the donor lymphocytes. In contrast, primary T cells from
a specific donor exhibited unusual downregulation by the
class II elements. These observations demonstrate that the
TATA- and class II box-containing DNA regions are impor-
tant components of DRA gene activation in primary T
lymphocytes, but the class II box may serve a negative role
under some circumstances. Thus, this study reveals dynamic
changes in the transcriptional control of DRA that have not
been previously appreciated with transformed cells.
The TATA region is bound by the trans-acting TFIID
(TBP) protein to form the transcription initiation complex
and serves to guide DNA polymerase to the proper down-
stream start site (3, 7, 14, 15). Its role in class II MHC
promoter has been disputed because linker scanning analysis
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and gamma interferon-induced macrophages suggests that
the TATA or TATA-like region is not as critical for proper
initiation as the upstream X and Y elements (43). Our finding
that TATA plays a predominant role in the absence of the
class II box is particularly unexpected because a review also
indicates that the DRA TATA is not functional (3). How-
ever, the paper cited in this review actually implied that the
TATA box may be utilized for basal transcription (39),
although actual mutation of the TATA box was not per-
formed. Multiple experiments performed here utilizing site-
directed mutations of sequences immediately flanking the
TATA region suggest these flanking regions do not contain
identifiable positive regulatory sequences. In contrast, a
complete mutation of the TATA box eliminated transcrip-
tional activation in activated primary T cells, and substitu-
tion of the DRA TATA with a SV40 TATA also diminished
gene expression. A similar approach has been used to
elucidate the functional dependency of adenoviral ElA on a
specific TATA box (2, 35). Our result would suggest that
different TATA boxes do not serve identical function. Taken
together, these experiments strongly suggest a role for the
TATA element in DRA gene expression.
Our functional analysis of the TATA box was extended to
transformed cell lines by using site-specific mutants. The
data unequivocally show that mutation of this element
completely abrogated CAT reporter gene expression and
produced aberrantly initiated transcripts in a cell-free tran-
scription system. These experiments were performed multi-
ple times, and the results have been striking and consistent.
The following could explain the difference between our
study and others. First, species-specific requirement for the
TATA box could explain the difference between human and
murine cells. Many TATA-less promoters exist, and some
elements such as the SP-1 sequence have been shown to
serve a similar role in fixing initiation sites and in interacting
indirectly with the TFIID complex (15). These other class II
MHC promoters likely contain these other sequences. Sec-
ond, the difference in the requirement of DRA TATA motif
in the two studies may be attributed to differences in the
detection system or in the cells analyzed. Both the transcrip-
tion initiation site and the production of an end product
(CAT) were assayed in our study, while the other study did
not examine the former issue. It is possible for functional
CAT proteins to be produced even if the transcripts are
initiating from a site other than the correct and usual site.
Another explanation may be inherent differences in the cells
or growth conditions of the cells. For example, in our hands
the TATA-containing region exhibited moderate transcrip-
tion activity during early T-cell stimulation, but not at a
delayed time.
The class II X and/or Y promoter element is critical for
constitutive expression of class II antigen in B-cell lines, in
gamma interferon-induced cells, and in class II positive
immune cells in transgenic mice. Our 5'A-109 constructs also
showed the importance of X and Y elements for induced
expression in human primary T cells. For the majority of
donors tested, T cells appear to require both the X and Y
boxes. This is similar to that observed with B cells from
transgenic mice. However, in transgenic mice a major pro-
portion of B cells requires the Y box and a minor population
requires the X box for class II gene expression. In contrast,
thymic epithelial cells only require the X box for proper
transcription, whereas macrophages rely solely on the Y
element (41). We are currently separating T cells into sub-
populations to determine if the exclusive usage of either the
X box or the Y box exists in subpopulations of T cells.
Another point of investigation is the DNA-binding proteins
that are specific for the class II elements. A number of
DNA-binding proteins have been shown to bind these two
elements, including NF-Y/YEBP and YB-1 specific for the Y
box, and RF-X, NF-X, and hXBP-1 specific for the X box. It
is of interest to determine if these DNA-binding proteins are
altered in expression and/or function during T-cell activa-
tion. In contrast to the class II elements, the octamer
element is unique to DRA and appears to have little influence
on promoter induction during the early phase of T-cell
activation. A 5' A-53 deletion construct which contains
octamer and TATA boxes showed identical induction of
CAT activity as the 5' A43 deletion construct containing
TATA only (data not shown).
T-cell lines maintained long term in vitro by constant
antigen stimulation and interleukin-2 were not used in this
study, although many express HLA class II antigens (10,
25). However, they may not reflect as closely the in vivo
physiologic situation as freshly isolated T cells. This is
underscored by our kinetic study which reveals shifts in
promoter usage in activated T cells depending on the time of
assay. All T cells stimulated by alloantigens, peptide anti-
gens, anti-CD3, or PHA showed predominant usage of the
TATA-containing region during the first period of stimula-
tion. In each case, the inclusion of the X and Y elements
augmented the transcriptional activity. However, an aug-
mentation of the class II box also was observed in allogeneic
or anti-CD3-stimulated T cells at a late time (day 6) with a
diminished effect of the TATA-containing region. This re-
veals dynamic changes in the transcriptional control of DRA
that have not been previously appreciated with transformed
cells.
Interestingly, a specific donor with a higher percentage of
DR' T cells showed strong CAT expression with 5'A-43
construct prior to any stimulation. The presence of the class
II box actually produced a dramatic suppression of CAT
expression at day 0. Analysis of this donor's lymphocytes 24
and 48 h after mitogen stimulation showed a relief from the
suppressive effect of the class II box. Most important, this is
correlated with an actual enhancement of DR' T cells. At
later times, the percentage of DR' T cells returned to
prestimulated levels, and the suppressive role of the class II
box was again observed. Reanalysis of this kinetic study
using this donor has not been possible because of insufficient
numbers of cells and infrequent availability of these donors;
however, a similar observation was made for two other
donors. These results suggest the involvement of a negative
factor which may bind or interact with either or both of the
X and Y elements to control DRA gene expression prior to
mitogen stimulation. A candidate for such a negative regu-
lator is YB-1, which binds the Y box of the DRA promoter.
YB-1 has been shown to downregulate DRA-CAT expres-
sion and subsequently decrease class II MHC mRNA and
cell surface antigen expression (9). Such a mechanism may
also be critical in primary T cells normally silenced for class
II expression.
In summary, the molecular analysis of activated DR' T
lymphocytes has revealed several novel features of gene
regulation. Some of these features are dramatically different
from that observed with transformed cells and underscore
the significance of such studies despite technical and logistic
difficulties of these analyses. The dynamic nature of these
pathways is likely to reveal mechanisms of general and
broad relevance to T-cell activation.
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